These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10029108)

  • 61. Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine.
    Dutta AK; Verghese VP; Pemde HK; Mathew LG; Ortiz E
    Indian Pediatr; 2009 Nov; 46(11):975-82. PubMed ID: 19955579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.
    Diaz-Mitoma F; Halperin SA; Tapiero B; Hoffenbach A; Zappacosta PS; Radley D; Bradshaw S; Martin JC; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
    Vaccine; 2011 Feb; 29(6):1324-31. PubMed ID: 21134456
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunization of the premature infant.
    D'Angio CT
    Pediatr Infect Dis J; 1999 Sep; 18(9):824-5. PubMed ID: 10493346
    [No Abstract]   [Full Text] [Related]  

  • 64. Surveillance of the safety of simultaneous administration of vaccines. The Centers for Disease Control and Prevention experience.
    Chen RT; Haber P; Mullen JR
    Ann N Y Acad Sci; 1995 May; 754():309-20. PubMed ID: 7625667
    [No Abstract]   [Full Text] [Related]  

  • 65. Recommended Childhood Immunization Schedule--United States, January-June 1996.
    Gindler J
    Clin Pediatr (Phila); 1996 Apr; 35(4):223-5. PubMed ID: 8665759
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Childhood immunizations 2000. Introduction.
    Lutwick LI; Rubin LG
    Pediatr Clin North Am; 2000 Apr; 47(2):xi-xiv. PubMed ID: 10761503
    [No Abstract]   [Full Text] [Related]  

  • 67. International prospects for combined vaccines with emphasis on quadrivalent diphtheria-tetanus-pertussis-hepatitis B vaccine.
    Melnick JL
    Ann N Y Acad Sci; 1995 May; 754():267-72. PubMed ID: 7625661
    [No Abstract]   [Full Text] [Related]  

  • 68. Immunization recommendations expanded for hepatitis B, HPV, pertussis vaccines.
    Kuehn BM
    JAMA; 2012 Apr; 307(13):1353-4. PubMed ID: 22474190
    [No Abstract]   [Full Text] [Related]  

  • 69. Poliovirus vaccine policy.
    Bader M
    Am J Dis Child; 1990 Apr; 144(4):453-4. PubMed ID: 2321608
    [No Abstract]   [Full Text] [Related]  

  • 70. Community participation boosts immunization coverage.
    Kowli SS; Bhalerao VR; Jagtap AS; Shrivastav R
    World Health Forum; 1990; 11(2):169-72. PubMed ID: 2271093
    [No Abstract]   [Full Text] [Related]  

  • 71. Combined childhood immunizations.
    Paradiso PR
    JAMA; 1992 Oct; 268(13):1685. PubMed ID: 1482490
    [No Abstract]   [Full Text] [Related]  

  • 72. [Pilot study on compulsory vaccination coverage].
    Grandolfo ME; Lauria L; Medda E; Bucciarelli M; Andreozzi S; Salinetti S; Sitzia G; Bernacchia R
    Ann Ist Super Sanita; 1999; 35(2):341-7. PubMed ID: 10645670
    [TBL] [Abstract][Full Text] [Related]  

  • 73. From the Centers for Disease Control and Prevention. Supply diphtheria and tetanus toxoids and acellular pertussis vaccine.
    JAMA; 2002 Feb; 287(5):579. PubMed ID: 11838447
    [No Abstract]   [Full Text] [Related]  

  • 74. From the Centers for Disease Control. FDA approval of use of diphtheria and tetanus toxoids and acellular pertussis vaccine.
    JAMA; 1992 Jan 22-29; 267(4):485. PubMed ID: 1729566
    [No Abstract]   [Full Text] [Related]  

  • 75. From the Centers of Disease Control and Prevention. Recommended childhood immunization schedule--United States, 2002.
    JAMA; 2002 Feb; 287(6):707-8. PubMed ID: 11855384
    [No Abstract]   [Full Text] [Related]  

  • 76. From the Centers for Disease Control. FDA approval of second diphtheria, tetanus toxoids, and acellular pertussis vaccine.
    JAMA; 1992 Oct; 268(14):1834, 1837. PubMed ID: 1404700
    [No Abstract]   [Full Text] [Related]  

  • 77. From the Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission--United States.
    JAMA; 1999 Mar; 281(9):790. PubMed ID: 10070986
    [No Abstract]   [Full Text] [Related]  

  • 78. Subpotent vaccine lot recalled, recommendations on supplemental doses issued.
    Am J Health Syst Pharm; 1999 Mar; 56(6):504. PubMed ID: 10192682
    [No Abstract]   [Full Text] [Related]  

  • 79. Global routine vaccination coverage, 2014.
    Wkly Epidemiol Rec; 2015 Nov; 90(46):617-23. PubMed ID: 26567398
    [No Abstract]   [Full Text] [Related]  

  • 80. From the Centers for Disease Control and Prevention. FDA approval of a second acellular pertussis vaccine for use among infants and young children.
    JAMA; 1997 Mar; 277(10):783. PubMed ID: 9052694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.